What is Yuhan Corporation's contact information?

Yuhan Corporation's contact information: 02-828-0181, +8228280181.

How many employees does Yuhan Corporation have?

Yuhan Corporation has 500 employees.

What are Yuhan Corporation's official social media profiles?

Yuhan Corporation Linkedin Page

What tech stack does Yuhan Corporation use?

Some of the popular technologies that Yuhan Corporation uses are: Google Ads, Google Analytics, Google Ads Conversion Tracking, jsDelivr.

What are Yuhan Corporation's office addresses?

Yuhan Corporation has 3 known office addresses: 서울특별시 동작구 노량진로 74 KR 74 Noryangjin-ro, Dongjak-gu, Seoul Teugbyeolsi, Kr, 06927.

What is Yuhan Corporation's estimated annual revenue?

Yuhan Corporation's revenue is $1,450,000,000

What is Yuhan Corporation's open headcount?

Yuhan Corporation has one job posting.

What is the number of ad campaigns for Yuhan Corporation?

Yuhan Corporation has no advertisements yet.

What is the number of recent news articles about Yuhan Corporation?

Yuhan Corporation has 154 news articles.

Yuhan Corporation - Pubrio Company Profile & Intent

Q: What industry does Yuhan Corporation belong to?

Yuhan Corporation is in the industry of: Pharmaceuticals, Health & Wellness, Pharmaceutical Manufacturing, Research & Development.

Yuhan Corporation

South Korea · Pharmaceutical Manufacturing

Pharmaceuticals

Health & Wellness

Pharmaceutical Manufacturing

Research & Development

Yuhan Corporation is an integrated healthcare company founded in 1926. It has achieved top market value and sales revenue in Korean pharmaceutical industries, and been awarded for the most respected and trusted company in Korea for recent 11 consecutive years. It has two subsidiaries, Yuhan Chemical and Yuhan Medica, and the affiliates including Joint Ventures with Janssen(Belgium), the Clorox Company(USA), and Kimbery-Clark Corporation(USA). The core business of Yuhan can be classified into Primary & Specialty care, Dietary supplement, Household & Animal care, and contract manufacturing of active pharmaceutical ingredients.

Company Insights

digitaltoday.co.kr · sells_assets_to · one day ago

Open news

GI Innovation Major Shareholder Reduces Stake

GI Innovation's major shareholder Jang Myung Ho reduced holdings by 13.337 million shares, decreasing stake from 26.49% to 6.63%. The reduction includes changes in special relationships and stock-secured loan arrangements.

docdocdoc.co.kr · is_developing · one day ago

Open news

Yuhan Targets First-in-Class TPD Drugs

Yuhan Corporation adopts first-in-class strategy focusing on Targeted Protein Degradation (TPD) platform to tackle undruggable targets through collaboration-based approach.

epnc.co.kr · recognized_as · 2 days ago

Open news

Yuhan Tops March Pharma Consumer Interest

Yuhan Corporation ranked first in consumer interest among pharmaceutical companies in March 2026 with 9,376 online postings, followed by Hanmi Pharm and Dong-A Pharmaceutical.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

coinreaders.com · launches · 2026-03-02

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Get full access to view complete information

1 - 25 of 154

Frequently Asked Questions Regarding Yuhan Corporation

Company Overview

1926

Founded

Pharmaceutical Manufacturing

Industry

South Korea

Location

7,450,672

Ranking

500 employees

Size

Similar Companies

Get full access to view complete information